Outstanding issues in use of disease-modifying agents in rheumatoid arthritis

Lancet. 1999 Jan 23;353(9149):257-8. doi: 10.1016/s0140-6736(05)74938-2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Humans
  • Treatment Outcome

Substances

  • Antirheumatic Agents